Free Trial

Citius Pharmaceuticals (CTXR) News Today

$0.73
-0.04 (-5.17%)
(As of 07/12/2024 ET)
Citius Pharmaceuticals logo with Medical background
Citius Pharmaceuticals (NASDAQ:CTXR) Stock Price Up 13.7%
Citius Pharmaceuticals (NASDAQ:CTXR) Shares Up 13.7%
Citius Pharmaceuticals logo with Medical background
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Short Interest Update
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR - Get Free Report) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 15,910,000 shares, an increase of 9.9% from the May 15th total of 14,480,000 shares. Based on an average daily trading volume, of 1,500,000 shares, the days-to-cover ratio is presently 10.6 days.
Citius Pharmaceuticals' (CTXR) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $4.00 price objective on shares of Citius Pharmaceuticals in a research note on Friday.
Citius Pharmaceuticals (NASDAQ:CTXR) Trading Up 4.1%
Citius Pharmaceuticals (NASDAQ:CTXR) Trading 4.1% Higher
Citius Pharmaceuticals (NASDAQ:CTXR) Stock Price Down 3.1%
Citius Pharmaceuticals (NASDAQ:CTXR) Trading Down 3.1%
CTXR Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals (NASDAQ:CTXR) Trading Down 3.8%
Citius Pharmaceuticals (NASDAQ:CTXR) Shares Down 3.8%
CTXR Apr 2024 7.500 put
CTXR May 2024 2.500 call
Citius Pharmaceuticals Inc
FY2024 Earnings Estimate for Citius Pharmaceuticals, Inc. Issued By HC Wainwright (NASDAQ:CTXR)
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR - Free Report) - Equities researchers at HC Wainwright issued their FY2024 EPS estimates for shares of Citius Pharmaceuticals in a research note issued on Tuesday, January 16th. HC Wainwright analyst V. Bernardino forecasts that the company will earn ($0.
Citius Ekes out Gains as Trials End
Citius Pharmaceuticals (CTXR) Scheduled to Post Earnings on Wednesday
Citius Pharmaceuticals (NASDAQ:CTXR) will be releasing earnings on Wednesday, December 20, Yahoo Finance reports.
Citius Pharmaceuticals Inc CTXR
Get Citius Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter.

I’ve seen this situation a handful of times in my life (Ad)

The stock is now trading for just $10 a share. Why is this company being ignored by Wall Street, and what kind of gains could shareholders soon be looking at?

In my new video, I outline everything I believe is going to happen with this company. 

CTXR Media Mentions By Week

CTXR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CTXR
News Sentiment

0.77

0.89

Average
Medical
News Sentiment

CTXR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CTXR Articles
This Week

5

1

CTXR Articles
Average Week

Get Citius Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CTXR) was last updated on 7/13/2024 by MarketBeat.com Staff

From Our Partners